205 related articles for article (PubMed ID: 21540458)
21. Differential expression of natural killer cell receptors (CD94/NKG2A) on T cells by the stimulation of G-CSF-mobilized peripheral blood mononuclear cells with anti-CD3 monoclonal antibody and cytokines: a study in stem cell donors.
Tanaka J; Toubai T; Miura Y; Tsutsumi Y; Kato N; Umehara S; Toyoshima N; Ohta S; Asaka M; Imamura M
Transplant Proc; 2004 Oct; 36(8):2511-2. PubMed ID: 15561299
[TBL] [Abstract][Full Text] [Related]
22. Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit.
Tanaka J; Sugita J; Kato N; Toubai T; Ibata M; Shono Y; Ota S; Kondo T; Kobayashi T; Kobayashi M; Asaka M; Imamura M
Exp Hematol; 2007 Oct; 35(10):1562-6. PubMed ID: 17681668
[TBL] [Abstract][Full Text] [Related]
23. Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8⁺ T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia.
Pump WC; Kraemer T; Huyton T; Hò GT; Blasczyk R; Bade-Doeding C
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909402
[TBL] [Abstract][Full Text] [Related]
24. Cutting edge: engagement of NKG2A on CD8+ effector T cells limits immunopathology in influenza pneumonia.
Zhou J; Matsuoka M; Cantor H; Homer R; Enelow RI
J Immunol; 2008 Jan; 180(1):25-9. PubMed ID: 18096998
[TBL] [Abstract][Full Text] [Related]
25. Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusions.
Pace E; Di Sano C; Ferraro M; Tipa A; Olivieri D; Spatafora M; Santagata R; Bellia V; Gjomarkaj M
Eur J Cancer; 2011 Jan; 47(2):296-304. PubMed ID: 20932742
[TBL] [Abstract][Full Text] [Related]
26. Structure of the murine CD94-NKG2A receptor in complex with Qa-1
MacLachlan BJ; Sullivan LC; Brooks AG; Rossjohn J; Vivian JP
FEBS J; 2024 Apr; 291(7):1530-1544. PubMed ID: 38158698
[TBL] [Abstract][Full Text] [Related]
27. Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells.
Kamiya T; Seow SV; Wong D; Robinson M; Campana D
J Clin Invest; 2019 May; 129(5):2094-2106. PubMed ID: 30860984
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of Fas and downregulation of CD94/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis.
Son SW; Kim EO; Ryu ES; Kim TJ; Kim JN; Choi JE; Kye YC; Lee KM
Br J Dermatol; 2009 Aug; 161(2):281-8. PubMed ID: 19438461
[TBL] [Abstract][Full Text] [Related]
29. Differential induction of CD94 and NKG2 in CD4 helper T cells. A consequence of influenza virus infection and interferon-gamma?
Graham CM; Christensen JR; Thomas DB
Immunology; 2007 Jun; 121(2):238-47. PubMed ID: 17462078
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor-beta-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes.
Bertone S; Schiavetti F; Bellomo R; Vitale C; Ponte M; Moretta L; Mingari MC
Eur J Immunol; 1999 Jan; 29(1):23-9. PubMed ID: 9933082
[TBL] [Abstract][Full Text] [Related]
31. Increased frequency of human leukocyte antigen-E inhibitory receptor CD94/NKG2A-expressing peritoneal natural killer cells in patients with endometriosis.
Galandrini R; Porpora MG; Stoppacciaro A; Micucci F; Capuano C; Tassi I; Di Felice A; Benedetti-Panici P; Santoni A
Fertil Steril; 2008 May; 89(5 Suppl):1490-6. PubMed ID: 17706207
[TBL] [Abstract][Full Text] [Related]
32. Development and function of CD94-deficient natural killer cells.
Orr MT; Wu J; Fang M; Sigal LJ; Spee P; Egebjerg T; Dissen E; Fossum S; Phillips JH; Lanier LL
PLoS One; 2010 Dec; 5(12):e15184. PubMed ID: 21151939
[TBL] [Abstract][Full Text] [Related]
33. Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway.
Lu L; Ikizawa K; Hu D; Werneck MB; Wucherpfennig KW; Cantor H
Immunity; 2007 May; 26(5):593-604. PubMed ID: 17509909
[TBL] [Abstract][Full Text] [Related]
34. IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2.
Ota T; Takeda K; Akiba H; Hayakawa Y; Ogasawara K; Ikarashi Y; Miyake S; Wakasugi H; Yamamura T; Kronenberg M; Raulet DH; Kinoshita K; Yagita H; Smyth MJ; Okumura K
Blood; 2005 Jul; 106(1):184-92. PubMed ID: 15746081
[TBL] [Abstract][Full Text] [Related]
35. Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.
Nielsen N; Pascal V; Fasth AE; Sundström Y; Galsgaard ED; Ahern D; Andersen M; Baslund B; Bartels EM; Bliddal H; Feldmann M; Malmström V; Berg L; Spee P; Söderström K
Immunology; 2014 Aug; 142(4):581-93. PubMed ID: 24673109
[TBL] [Abstract][Full Text] [Related]
36. The effect of mifepristone on the peripheral blood natural killer cell's cytotoxicity and expression of CD94/NKG2A and NKG2D during the implantation phase.
Chen XY; Zhuang YL; Li L; Zhang WW; Huang LL
Fertil Steril; 2010 May; 93(8):2615-20. PubMed ID: 19880106
[TBL] [Abstract][Full Text] [Related]
37. NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes.
Borrego F; Kabat J; Sanni TB; Coligan JE
J Immunol; 2002 Dec; 169(11):6102-11. PubMed ID: 12444112
[TBL] [Abstract][Full Text] [Related]
38. Preferential survival of CD8 T and NK cells expressing high levels of CD94.
Gunturi A; Berg RE; Forman J
J Immunol; 2003 Feb; 170(4):1737-45. PubMed ID: 12574337
[TBL] [Abstract][Full Text] [Related]
39. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis.
Correale J; Villa A
J Neuroimmunol; 2008 Mar; 195(1-2):121-34. PubMed ID: 18234356
[TBL] [Abstract][Full Text] [Related]
40. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor.
Brooks AG; Posch PE; Scorzelli CJ; Borrego F; Coligan JE
J Exp Med; 1997 Feb; 185(4):795-800. PubMed ID: 9034158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]